Skip to main content
Erschienen in: Endocrine 1/2012

01.02.2012 | Original Article

Coexistence of non-alcoholic fatty liver disease with elevated alanine aminotransferase is associated with insulin resistance in young Han males

verfasst von: Rui Wang, Qiang Lu, Ji Feng, Fuzai Yin, Chunmei Qin, Bo Liu, Yali Liu, Xiaoli Liu

Erschienen in: Endocrine | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Elevated alanine aminotransferase (ALT) and non-alcoholic fatty liver disease (NAFLD) have been associated with insulin resistance (IR). The objective of this study was to determine whether elevated ALT and NAFLD were useful for early and definitive determination of IR and to compare their coexistence with conventional risk factors in young Han males. Anthropometric and metabolic measurements were assessed in 216 young Han males (19.3 ± 0.8 years). NAFLD was diagnosed using ultrasonography, and the homeostasis model assessment of insulin resistance (HOMA-IR) served as an index of IR. Subjects in the fourth HOMA-IR quartile had a significantly higher frequency of abdominal obesity, elevated blood pressure and ALT, and NAFLD compared to subjects in quartiles 1–3 (P < 0.05). Using multivariate logistic regression analysis, risk of IR increased by 2.33-fold (95% CI: 1.00–5.42, P = 0.050) in participants with NAFLD. In addition, the coexistence of NAFLD and elevated ALT were significantly associated with HOMA-IR and participants with both elevated ALT and NAFLD had a 4.65-fold (95% CI: 1.55–13.97, P = 0.006) increased risk of IR. Coexistence of NAFLD and elevated ALT are associated with IR in young Han males and might be useful for early detection of IR as compared to conventional risk factors.
Literatur
1.
Zurück zum Zitat T. Watanabe, T. Suguro, K. Sato, T. Koyama, M. Nagashima, S. Kodate, T. Hirano, M. Adachi, M. Shichiri, A. Miyazaki, Serum salusin-alpha levels are increased and correlated negatively with carotid atherosclerosis in essential hypertensive patients. Hypertens. Res. 31, 463–468 (2008)PubMedCrossRef T. Watanabe, T. Suguro, K. Sato, T. Koyama, M. Nagashima, S. Kodate, T. Hirano, M. Adachi, M. Shichiri, A. Miyazaki, Serum salusin-alpha levels are increased and correlated negatively with carotid atherosclerosis in essential hypertensive patients. Hypertens. Res. 31, 463–468 (2008)PubMedCrossRef
2.
Zurück zum Zitat J.P. Strong, G.T. Malcom, C.A. McMahan, R.E. Tracy, W.P. Newman 3rd, E.E. Herderick, J.F. Cornhill, Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA 281, 727–735 (1999)PubMedCrossRef J.P. Strong, G.T. Malcom, C.A. McMahan, R.E. Tracy, W.P. Newman 3rd, E.E. Herderick, J.F. Cornhill, Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA 281, 727–735 (1999)PubMedCrossRef
3.
Zurück zum Zitat I. Grattagliano, P. Portincasa, V.O. Palmieri, G. Palasciano, Managing nonalcoholic fatty liver disease: recommendations for family physicians. Can. Fam. Physician 53, 857–863 (2007)PubMed I. Grattagliano, P. Portincasa, V.O. Palmieri, G. Palasciano, Managing nonalcoholic fatty liver disease: recommendations for family physicians. Can. Fam. Physician 53, 857–863 (2007)PubMed
4.
Zurück zum Zitat C.M. Ferrara, A.P. Goldberg, Limited value of the homeostasis model assessment to predict insulin resistance in older men with impaired glucose tolerance. Diabetes Care 24, 245–249 (2001)PubMedCrossRef C.M. Ferrara, A.P. Goldberg, Limited value of the homeostasis model assessment to predict insulin resistance in older men with impaired glucose tolerance. Diabetes Care 24, 245–249 (2001)PubMedCrossRef
5.
Zurück zum Zitat J. Yoo, S. Lee, K. Kim, S. Yoo, E. Sung, J. Yim, Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children. Diabetes Res. Clin. Pract. 81, 321–326 (2008)PubMedCrossRef J. Yoo, S. Lee, K. Kim, S. Yoo, E. Sung, J. Yim, Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children. Diabetes Res. Clin. Pract. 81, 321–326 (2008)PubMedCrossRef
6.
Zurück zum Zitat D.F. Chan, A.M. Li, W.C. Chu, M.H. Chan, E.M. Wong, E.K. Liu, I.H. Chan, J. Yin, C.W. Lam, T.F. Fok, E.A. Nelson, Hepatic steatosis in obese Chinese children. Int. J. Obes. Relat. Metab. Disord. 28, 1257–1263 (2004)PubMedCrossRef D.F. Chan, A.M. Li, W.C. Chu, M.H. Chan, E.M. Wong, E.K. Liu, I.H. Chan, J. Yin, C.W. Lam, T.F. Fok, E.A. Nelson, Hepatic steatosis in obese Chinese children. Int. J. Obes. Relat. Metab. Disord. 28, 1257–1263 (2004)PubMedCrossRef
7.
Zurück zum Zitat G. Marchesini, M. Brizi, A.M. Morselli-Labate, G. Bianchi, E. Bugianesi, A.J. McCullough, G. Forlani, N. Melchionda, Association of nonalcoholic fatty liver disease with insulin resistance. Am. J. Med. 107, 450–455 (1999)PubMedCrossRef G. Marchesini, M. Brizi, A.M. Morselli-Labate, G. Bianchi, E. Bugianesi, A.J. McCullough, G. Forlani, N. Melchionda, Association of nonalcoholic fatty liver disease with insulin resistance. Am. J. Med. 107, 450–455 (1999)PubMedCrossRef
8.
Zurück zum Zitat A. Sonsuz, M. Basaranoglu, M. Bilir, H. Senturk, P. Akin, Hyperinsulinemia in nondiabetic, both obese and nonobese patients with nonalcoholic steatohepatitis. Am. J. Gastroenterol. 97, 495 (2002)PubMedCrossRef A. Sonsuz, M. Basaranoglu, M. Bilir, H. Senturk, P. Akin, Hyperinsulinemia in nondiabetic, both obese and nonobese patients with nonalcoholic steatohepatitis. Am. J. Gastroenterol. 97, 495 (2002)PubMedCrossRef
9.
10.
Zurück zum Zitat T.S. Burgert, S.E. Taksali, J. Dziura, T.R. Goodman, C.W. Yeckel, X. Papademetris, R.T. Constable, R. Weiss, W.V. Tamborlane, M. Savoye, A.A. Seyal, S. Caprio, Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J. Clin. Endocrinol. Metab. 91, 4287–4294 (2006)PubMedCrossRef T.S. Burgert, S.E. Taksali, J. Dziura, T.R. Goodman, C.W. Yeckel, X. Papademetris, R.T. Constable, R. Weiss, W.V. Tamborlane, M. Savoye, A.A. Seyal, S. Caprio, Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J. Clin. Endocrinol. Metab. 91, 4287–4294 (2006)PubMedCrossRef
11.
Zurück zum Zitat S. Deivanayagam, B.S. Mohammed, B.E. Vitola, G.H. Naguib, T.H. Keshen, E.P. Kirk, S. Klein, Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents. Am. J. Clin. Nutr. 88, 257–262 (2008)PubMed S. Deivanayagam, B.S. Mohammed, B.E. Vitola, G.H. Naguib, T.H. Keshen, E.P. Kirk, S. Klein, Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents. Am. J. Clin. Nutr. 88, 257–262 (2008)PubMed
12.
Zurück zum Zitat E.S. Ford, C. Li, G. Zhao, Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. J. Diabetes 2, 180–193 (2010)PubMedCrossRef E.S. Ford, C. Li, G. Zhao, Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. J. Diabetes 2, 180–193 (2010)PubMedCrossRef
13.
Zurück zum Zitat Z.J. Yang, W.Y. Yang, X.P. Chen, G.W. Li, The optimal waist circumference cut-off point for identifying cardiovascular risk factors clustering among Chinese adults. Zhonghua Nei Ke Za Zhi 45, 372–375 (2006). (in Chinese)PubMed Z.J. Yang, W.Y. Yang, X.P. Chen, G.W. Li, The optimal waist circumference cut-off point for identifying cardiovascular risk factors clustering among Chinese adults. Zhonghua Nei Ke Za Zhi 45, 372–375 (2006). (in Chinese)PubMed
14.
Zurück zum Zitat G.C. Farrell, S. Chitturi, G.K. Lau, J.D. Sollano, Asia-Pacific Working Party on NAFLD, Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J. Gastroenterol. Hepatol. 22, 775–777 (2007)PubMedCrossRef G.C. Farrell, S. Chitturi, G.K. Lau, J.D. Sollano, Asia-Pacific Working Party on NAFLD, Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J. Gastroenterol. Hepatol. 22, 775–777 (2007)PubMedCrossRef
15.
Zurück zum Zitat Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adult, Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285, 2486–2497 (2001)CrossRef Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adult, Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285, 2486–2497 (2001)CrossRef
16.
Zurück zum Zitat D. Prati, E. Taioli, A. Zanella, E. Della Torre, S. Butelli, E. Del Vecchio, L. Vianello, F. Zanuso, F. Mozzi, S. Milani, D. Conte, M. Colombo, G. Sirchia, Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann. Intern. Med. 137, 1–10 (2002)PubMed D. Prati, E. Taioli, A. Zanella, E. Della Torre, S. Butelli, E. Del Vecchio, L. Vianello, F. Zanuso, F. Mozzi, S. Milani, D. Conte, M. Colombo, G. Sirchia, Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann. Intern. Med. 137, 1–10 (2002)PubMed
17.
Zurück zum Zitat A.A. Patel, D.M. Torres, S.A. Harrison, Effect of weight loss on nonalcoholic fatty liver disease. J. Clin. Gastroenterol. 43, 970–974 (2009)PubMedCrossRef A.A. Patel, D.M. Torres, S.A. Harrison, Effect of weight loss on nonalcoholic fatty liver disease. J. Clin. Gastroenterol. 43, 970–974 (2009)PubMedCrossRef
18.
Zurück zum Zitat J.G. Fan, G.C. Farrell, Epidemiology of non-alcoholic fatty liver disease in China. J. Hepatol. 50, 204–210 (2009)PubMedCrossRef J.G. Fan, G.C. Farrell, Epidemiology of non-alcoholic fatty liver disease in China. J. Hepatol. 50, 204–210 (2009)PubMedCrossRef
19.
Zurück zum Zitat Y. Eguchi, T. Eguchi, T. Mizuta, Y. Ide, T. Yasutake, R. Iwakiri, A. Hisatomi, I. Ozaki, K. Yamamoto, Y. Kitajima, Y. Kawaguchi, S. Kuroki, N. Ono, Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. J. Gastroenterol. 41, 462–469 (2006)PubMedCrossRef Y. Eguchi, T. Eguchi, T. Mizuta, Y. Ide, T. Yasutake, R. Iwakiri, A. Hisatomi, I. Ozaki, K. Yamamoto, Y. Kitajima, Y. Kawaguchi, S. Kuroki, N. Ono, Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. J. Gastroenterol. 41, 462–469 (2006)PubMedCrossRef
20.
Zurück zum Zitat G. Musso, R. Gambino, S. Bo, B. Uberti, G. Biroli, G. Pagano, M. Cassader, Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects. Diabetes Care 31, 562–568 (2008)PubMedCrossRef G. Musso, R. Gambino, S. Bo, B. Uberti, G. Biroli, G. Pagano, M. Cassader, Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects. Diabetes Care 31, 562–568 (2008)PubMedCrossRef
21.
Zurück zum Zitat J.G. Fan, Y.D. Peng, Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies. Hepatobiliary Pancreat. Dis. Int. 6, 572–578 (2007)PubMed J.G. Fan, Y.D. Peng, Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies. Hepatobiliary Pancreat. Dis. Int. 6, 572–578 (2007)PubMed
22.
Zurück zum Zitat A.J. Hanley, L.E. Wagenknecht, A. Festa, R.B. D’Agostino Jr, S.M. Haffner, Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study. Diabetes Care 30, 1819–1827 (2007)PubMedCrossRef A.J. Hanley, L.E. Wagenknecht, A. Festa, R.B. D’Agostino Jr, S.M. Haffner, Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study. Diabetes Care 30, 1819–1827 (2007)PubMedCrossRef
23.
Zurück zum Zitat C.C. Fu, M.C. Chen, Y.M. Li, T.T. Liu, L.Y. Wang, The risk factors for ultrasound-diagnosed non-alcoholic fatty liver disease among adolescents. Ann. Acad. Med. Singap. 38, 15–17 (2009)PubMed C.C. Fu, M.C. Chen, Y.M. Li, T.T. Liu, L.Y. Wang, The risk factors for ultrasound-diagnosed non-alcoholic fatty liver disease among adolescents. Ann. Acad. Med. Singap. 38, 15–17 (2009)PubMed
24.
Zurück zum Zitat M.R. Salazar, H.A. Carbajal, J.O. Curciarello, M. Aizpurua, R.E. Adrover, B. Riondet, Alanin-aminotransferase: an early marker for insulin resistance? Medicina (B Aires) 67, 125–130 (2007) M.R. Salazar, H.A. Carbajal, J.O. Curciarello, M. Aizpurua, R.E. Adrover, B. Riondet, Alanin-aminotransferase: an early marker for insulin resistance? Medicina (B Aires) 67, 125–130 (2007)
25.
Zurück zum Zitat S.H. Park, B.I. Kim, H.J. Kim, H. Kim, S.H. Kim, D.I. Park, Y.K. Cho, I.K. Sung, C.I. Sohn, W.K. Jeon, D.K. Keum, Clinical features associated with improvement of fatty liver disease. Intern. Med. J. 35, 473–477 (2005)PubMedCrossRef S.H. Park, B.I. Kim, H.J. Kim, H. Kim, S.H. Kim, D.I. Park, Y.K. Cho, I.K. Sung, C.I. Sohn, W.K. Jeon, D.K. Keum, Clinical features associated with improvement of fatty liver disease. Intern. Med. J. 35, 473–477 (2005)PubMedCrossRef
26.
Zurück zum Zitat J.D. Browning, L.S. Szczepaniak, R. Dobbins, P. Nuremberg, J.D. Horton, J.C. Cohen, S.M. Grundy, H.H. Hobbs, Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40, 1387–1395 (2004)PubMedCrossRef J.D. Browning, L.S. Szczepaniak, R. Dobbins, P. Nuremberg, J.D. Horton, J.C. Cohen, S.M. Grundy, H.H. Hobbs, Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40, 1387–1395 (2004)PubMedCrossRef
27.
Zurück zum Zitat M.H. Fishbein, C. Mogren, T. Gleason, W.R. Stevens, Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease. J. Pediatr. Gastroenterol. Nutr. 42, 83–88 (2006)PubMed M.H. Fishbein, C. Mogren, T. Gleason, W.R. Stevens, Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease. J. Pediatr. Gastroenterol. Nutr. 42, 83–88 (2006)PubMed
28.
Zurück zum Zitat H.M. Yan, X. Gao, M. Liu, Q. Gu, B. Zhang, X. Li, Relationship of liver fat content to insulin resistance and metabolic syndrome. Zhonghua Yi Xue Za Zhi 88, 1255–1258 (2008). (in Chinese)PubMed H.M. Yan, X. Gao, M. Liu, Q. Gu, B. Zhang, X. Li, Relationship of liver fat content to insulin resistance and metabolic syndrome. Zhonghua Yi Xue Za Zhi 88, 1255–1258 (2008). (in Chinese)PubMed
29.
Zurück zum Zitat S.Y. Oh, Y.K. Cho, M.S. Kang, T.W. Yoo, J.H. Park, H.J. Kim, D.I. Park, C.I. Sohn, W.K. Jeon, B.I. Kim, B.H. Son, J.H. Shin, The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease. Metabolism 55, 1604–1609 (2006)PubMedCrossRef S.Y. Oh, Y.K. Cho, M.S. Kang, T.W. Yoo, J.H. Park, H.J. Kim, D.I. Park, C.I. Sohn, W.K. Jeon, B.I. Kim, B.H. Son, J.H. Shin, The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease. Metabolism 55, 1604–1609 (2006)PubMedCrossRef
Metadaten
Titel
Coexistence of non-alcoholic fatty liver disease with elevated alanine aminotransferase is associated with insulin resistance in young Han males
verfasst von
Rui Wang
Qiang Lu
Ji Feng
Fuzai Yin
Chunmei Qin
Bo Liu
Yali Liu
Xiaoli Liu
Publikationsdatum
01.02.2012
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 1/2012
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-011-9511-0

Weitere Artikel der Ausgabe 1/2012

Endocrine 1/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.